BridgeBio Oncology Therapeutics, Inc. (BBOT)
↓ Download CSVKey ratios (FY2025)
-32.6%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Income | -$145.82M | -$80.86M | -$41.7K | — |
| Net Income | -$134.04M | -$74.28M | -$41.7K | — |
| EPS (Diluted) | $-4.30 | $-5756.41 | — | — |
| Total Assets | $448.38M | $164.30M | $332.9K | — |
| Total Liabilities | $37.28M | $19.58M | $396.5K | — |
| Shareholders' Equity | $411.10M | -$178.64M | -$115.64M | -$21.9K |
| Cash & Equivalents | $373.69M | $30.85M | — | — |
| Operating Cash Flow | -$113.89M | -$55.03M | — | — |
| Capital Expenditures | $606.0K | $49.0K | — | — |
| Shares Outstanding | 79.99M | 28.4K | — | — |